Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myfortic in extensive chronic Graft versus Host Disease
NCT00298324Phase 3Terminated
- Start
- Sep 2006
- Primary completion
- Nov 2009
- Countries
- 8
01
Overview
A Phase 3 trial of mycophenolate sodium in chronic graft-versus-host disease (cGVHD). Started Sep 2006; status: terminated.
02
Drugs
mycophenolate sodium
03
Conditions
chronic graft-versus-host disease (cGVHD)
Beyond the preview
Go deeper on NCT00298324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00298324.